Category: drug development

Monoclonal antibodies target Herceptin

LATEST addition to the range of anti-idiotypic antibodies from AbD Serotec are used to target Herceptin (Trastuzumab), an anti-cancer drug. The six new antibodies are useful for monitoring patient serum for Herceptin levels, and have potential applications in preclinical research.…

Design a molecule, win an iPad

CAN YOU design a molecule biologically similar to, but not the same as, a specified reference compound? The task isn’t quite as easy as simply swapping an atom or two, as the newly-designed molecule must be synthetically tractable and drug-like,…

First commercially-available parvovirus panel

SERACARE Life Sciences has launched five new infectious disease panels, including the first for parvovirus B19 which is associated with fifth disease. The other new products include panels for human immunodeficiency virus (HIV), hepatitus A (HAV), hepatitus B (HBV), and cytomegalovirus…

Developing animal-free vaccine media

MOST vaccines today are manufactured using fetal bovine serum or other animal-based components, which raises important safety concerns over prion and viral contamination. This month, the US National Institutes of Health (NIH) made a Small Business Innovation Research (SBIR) grant…